Two Sigma Investments, LP Eledon Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.34 - $2.85 $9,380 - $19,950	-7,000 Reduced 39.8%	10,586 $14,000
Q1 2023 May 15, 2023	SELL	$2.0 - $3.46 $8,102 - $14,016	-4,051 Reduced 18.72%	17,586 $41,000
Q4 2022 Feb 14, 2023	SELL	$2.17 - $2.75 $17,577 - $22,275	-8,100 Reduced 27.24%	21,637 $49,000
Q3 2022 Nov 14, 2022	SELL	$2.45 - $3.88 $3,430 - $5,432	-1,400 Reduced 4.5%	29,737 $82,000
Q2 2022 Aug 15, 2022	SELL	$2.34 - $3.96 $87,396 - $147,902	-37,349 Reduced 54.54%	31,137 $76,000
Q1 2022 May 16, 2022	SELL	$3.06 - $4.89 $173,523 - $277,297	-56,707 Reduced 45.3%	68,486 $270,000
Q4 2021 Feb 14, 2022	BUY	$4.02 - $6.07 $39,673 - $59,904	9,869 Added 8.56%	125,193 $552,000
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.46 $343,415 - $489,106	57,814 Added 100.53%	115,324 $713,000
Q2 2021 Aug 16, 2021	BUY	$7.62 - $11.75 $151,950 - $234,306	19,941 Added 53.08%	57,510 $455,000
Q1 2021 May 17, 2021	BUY	$9.85 - $19.22 $370,054 - $722,076	37,569 New	37,569 $402,000

18.4M

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $57.2M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.